Tilray Brands, Inc. Impairment of Intangible Assets (Excluding Goodwill)
Tilray Brands, Inc. (TLRY) reported Impairment of Intangible Assets (Excluding Goodwill) of $0 for the 12-month period ending 2024-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2026-07-28
- Tilray Brands, Inc. impairment of intangible assets (excluding goodwill) for the quarter ending 2023-02-28 was $205.00M.
- Tilray Brands, Inc. impairment of intangible assets (excluding goodwill) for the quarter ending 2022-11-30 was $0.00.
- Tilray Brands, Inc. impairment of intangible assets (excluding goodwill) for the quarter ending 2022-08-31 was $210.84M.
- Tilray Brands, Inc. impairment of intangible assets (excluding goodwill) for the quarter ending 2020-12-31 was $0.00.
- Tilray Brands, Inc. impairment of intangible assets (excluding goodwill) for fiscal 2024 was $0.00.
- Tilray Brands, Inc. impairment of intangible assets (excluding goodwill) for fiscal 2019 was $106.69M.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 6 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month |
|---|---|---|---|---|
| 2024-05-31 | $0.00 10-K · filed 2026-07-28 | |||
| 2023-02-28 | $205.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | $205.00M derived: sum of 2 quarters · filed 2023-04-10 | $415.84M 10-Q · filed 2023-04-10 | |
| 2022-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | $210.84M 10-Q · filed 2023-01-09 | ||
| 2022-08-31 | $210.84M 10-Q · filed 2022-10-07 | |||
| 2022-05-31 | $210.84M 10-Q · filed 2023-04-10 | |||
| 2020-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2021-05-10 | -$64.00K derived: sum of 2 quarters · filed 2021-05-10 | $12.36M derived: sum of 3 quarters · filed 2021-05-10 | $35.19M 10-Q · filed 2021-05-10 |
| 2020-09-30 | -$64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $12.36M derived: sum of 2 quarters · filed 2020-11-09 | $35.19M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $12.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $35.26M 10-Q · filed 2020-08-10 | ||
| 2020-03-31 | $22.83M 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | $106.69M 10-K · filed 2021-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |